
MSGS Stock Forecast & Price Target
MSGS Analyst Ratings
Bulls say
Madison Square Garden is viewed favorably because its ownership of the Knicks and Rangers provides exposure to elite sports franchises whose third-party valuations remain materially above where the stock trades, supported by estimates such as the Knicks at roughly $9.75bn to $10.1bn and the Rangers at about $3.65bn to $4.0bn. The recent Knicks run to the NBA Finals has already lifted expected F4Q revenue to $246mm from $206mm, while the company’s F4QE AOI remains $31mm despite elevated playoff-related expenses, highlighting strong monetization from winning seasons even as costs rise. Further upside is tied to the progressing spin-off of the Knicks and Rangers, which is seen as an initial step toward unlocking sum-of-the-parts value, alongside longer-term catalysts such as NBA expansion in Las Vegas and Seattle that could yield $450mm-$700mm for the Knicks and the company’s unique position in the largest media market in the U.S.
Bears say
Madison Square Garden is facing a negative fundamental outlook because the recent revenue and AOI uplift from the Knicks’ historic NBA Championship run appears event-driven rather than durable, with F4Q revenue of $279mm and AOI of $40mm benefiting from on-court success that may not recur. Its value proposition remains heavily dependent on a complex spin-off process and hoped-for catalysts such as NBA expansion in Las Vegas and Seattle or European expansion, which adds execution risk while leaving the core business exposed to the volatility of team performance and league-dependent outcomes. Although third-party valuations for the Rangers and Knicks are materially above where the shares trade, the reliance on sum-of-the-parts optimism, recent market transaction comparables, and future league expansion assumptions suggests the current fundamental case is more fragile than the headline asset values imply.
This aggregate rating is based on analysts' research of Madison Square Garden Sports and is not a guaranteed prediction by Public.com or investment advice.
MSGS Analyst Forecast & Price Prediction
Start investing in MSGS
Order type
Buy in
Order amount
Est. shares
0 shares